Oncotype DX Used for Patients With Breast Cancer to Guide Therapy | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

Test Oncotype DX Breast Recurrence Score®: test genomowy dla kobiet z rakiem piersi

The Oncotype DX Breast Recurrence Score® test can help predict the chemotherapy benefit of a person with #BreastCancer.*​ Specifically, the test is for stage I-IIIA hormone receptor-positive, HER2-negative breast cancer. ​ Learn more about the Oncotype DX® test: https://bit.ly/41Js3Kr #CancerTreatment #CancerCare​ *Paik et al. J Clin Oncol. 2006;24(23):3726-3734; Albain et al. Lancet Oncol. 2010;11(1):55-65 | Until Everyone Knows

For Bola, cancer has been “extremely eye-opening.” “I have learned to embrace every single day.” —Bola, breast cancer survivor and Oncotype DX® Ambassador Tell us, how has cancer changed you? | Until Everyone Knows

“Right before I was diagnosed, I had just retired as a fifth grade teacher. If you told me then that I’d be teaching people about cancer, I would’ve said you were crazy. I am so blessed to be here, and to be able to share with you what I’ve learned through my journey, and give you hope for your journey.” — Judy, breast cancer survivor and Oncotype DX® Ambassador How has cancer changed YOU? Tell us in the comments 👇 #CancerSurvivorsMonth #NationalCancerSurvivorsMonth #HowCancerChangedMe #cancers